Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2005 / Cilt: 11 - Sayı: 3

Is there any difference in the management and metabolic features between patients with gestational diabetes and polycystic ovary syndrome and gestational diabetes alone?

Pages
167–170
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The perinatal outcomes seemed similar, as well.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: It has been reported that ultrasonographic polycystic ovary appearance was more prevalent in patients with a history of gestational diabetes mellitus (GDM), and that gestational diabetes mellitus was more prevalent in patients with polycystic ovary syndrome (PCOS).
📊
Key Findings & Data:STUDY DESIGN: The anthropometric variables, 50 g glucose challenge and 100 g oral glucose tolerance test results, fasting insulin levels, differences in the management of gestational diabetes and pregnancy outcomes were compared between patients with GDM and PCOS and GDM alone.
💡
Conclusion & Impact:The perinatal outcomes seemed similar, as well.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Gebelik sonucu · Erişkin · Glukoz tolerans testi

Abstract

OBJECTIVE: It has been reported that ultrasonographic polycystic ovary appearance was more prevalent in patients with a history of gestational diabetes mellitus (GDM), and that gestational diabetes mellitus was more prevalent in patients with polycystic ovary syndrome (PCOS). The purpose of this case-control study was to compare the metabolic features, management and pregnancy outcomes of patients with GDM regarding the presence or absence of PCOS. STUDY DESIGN: The anthropometric variables, 50 g glucose challenge and 100 g oral glucose tolerance test results, fasting insulin levels, differences in the management of gestational diabetes and pregnancy outcomes were compared between patients with GDM and PCOS and GDM alone. RESULTS: Although the patients with GDM and PCOS were more obese before pregnancy, there were no differences in glucose challenge and glucose tolerance test results, fasting insulin and weight gain during pregnancy. The need, the timing and the dosage of insulin therapy did not also differ according to the presence or absence of PCOS. Pregnancy outcomes were comparable between the groups, as well. CONCLUSıON: Women with PCOS and GDM share similar metabolic features with women with GDM alone. However, they were more obese before pregnancy. The management of patients did not also differ according to the presence or absence of PCOS. The perinatal outcomes seemed similar, as well.

🔖

Cite This Article

ERTUNÇ, D., TOK, E. C., ÇAYAN, F., BİLGİN, Ö., DİLEK, S. (2005). Is there any difference in the management and metabolic features between patients with gestational diabetes and polycystic ovary syndrome and gestational diabetes alone?. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 11 - Sayı: 3, 167–170. https://ajindex.com/articles/227187

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333:853-61
  2. Holte J. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baillieres Clin Endocrinol Metab 1996; 10:22.1-47
  3. Paradisi G, Fulghesu AM, Ferrazzani S, et al. Endocrinometabolic features in women with polycystic ovary syndrome during pregnancy. HumReprod 1998; 13:542-6
  4. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28:1039-57
  5. Stowers JM, Sutherland.HW, Kerridge DF. Long-range implications for the mother. The Aberdeen experience. Diabetes 1985; 34 (Suppl 2): 106-10
  6. Holte J, Gennarelli G, Wide L, Lithell H, Berne C. High prevalence of polycystic ovaries and associated clinical,endocrine, and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 1998; 83:1143-50
  7. Radon PA, McMahon MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 1999; 94:194-7
  8. Anttila L, Karjala K, Penttila RA, Ruutiainen K, Ekblad U. Polycystic ovaries in women with gestational diabetes. Obstet Gynecol 1998; 92:13-6
  9. Urman B, Sarac E, Dogan L, Gurgan T. Pregnancy in infertile PCOD patients. Complications and outcome. J Reprod Med 1997; 42:501-5
  10. Kousta E, Cela E, Lawrence N, et al. The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clin Endocrinol (Oxf) 2000; 53:501-7
  11. Gjonnaess H. The course and outcome of pregnancy after ovarian electrocautery in women with polycystic ovarian syndrome: the influence of body-weight. Br J Obstet Gynaecol 1989; 96:714-9. 12.Lanzone A, Caruso A, Di Simone N, De Carolis S, Fulghesu AM, Mancuso S. Polycystic ovary disease. A risk factor for gestational diabetes? J Reprod Med. 1995; 40:312-6. 13.Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001; 16:226-9. 14.Haakova L, Cibula D, Rezabek K, Hill M, Fanta M, Zivny J. Pregnancy outcome in women with PCOS and in controls matched by age and weight. Hum Reprod. 2003; 18:1438-41
  12. Turhan NO, Seçkin NC, Aybar F, Inegol I. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients. Int J Gynecol Obstet 2003; 81:163-8
  13. Harris JA, Benedict FG. A biometric study of basal metabolism in man. Washington: Carnegie Institution; 1919. Carnegie I